Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ELDN Eledon Pharmaceuticals

Watchlist
2.865
-0.075-2.55%
Close  02/07 16:00 ET
High
3.083
Open
2.880
Turnover
14.32K
Low
2.865
Pre Close
2.940
Volume
4.88K
Market Cap
39.41M
P/E(TTM)
Loss
52wk High
4.390
Shares
13.76M
P/E(Static)
Loss
52wk Low
2.030
Float Cap
28.95M
Bid/Ask %
-56.52%
Historical High
4864.865
Shs Float
10.11M
Volume Ratio
0.18
Historical Low
2.030
Dividend TTM
--
Div Yield TTM
--
P/B
0.28
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.05%
Amplitude
7.41%
Avg Price
2.931
Lot Size
1
Float Cap
28.95M
Bid/Ask %
-56.52%
Historical High
4864.865
Shs Float
10.11M
Volume Ratio
0.18
Historical Low
2.030
Dividend TTM
--
P/B
0.28
Dividend LFY
--
Turnover Ratio
0.05%
Amplitude
7.41%
Avg Price
2.931
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cellular transplant, and for people living with autoimmune and neurodegenerative disease. The firm’s compound in development is AT-1501, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L, also called CD154), a well-validated biological target with broad therapeutic potential. The CD40L/CD40 pathway is recognized for its prominent role in immune regulation, making it a candidate for therapeutic intervention in transplant tolerance, autoimmune disease, and neuro-inflammation. The company is building upon a deep historical understanding of the CD40/CD40L pathway, as well as preclinical and Phase 1 data, to initiate up to four phase 2 clinical studies with AT-1501. Eledon Pharmaceuticals was founded on March 26, 2004 and is headquartered in Irvine, CA.
CEO: Dr. David-Alexandre C. Gros, M.D.
Market: NASDAQ
Listing Date: 09/17/2014
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist